In agreement, survival analysis using LAG3 mRNA expression from 107 patients with CLL (GSE22762 dataset) revealed diminished overall survival (OS) in patients with high LAG3 expression (HR = 7.4, p < 0.001) (Figure 3B). The gene discussed is LAG3; the disease is B-cell chronic lymphocytic leukemia.